Safe Tussin DM Cough + Chest Congestion (Dextromethorphan HBr/ Cough Suppressant Guaifenesin/Expectorant), packaged i... — FDA record D-0942-2023

Reported terminated

Status as reported in the agency record. FDA warns that enforcement status may not track the current recall lifecycle; check the current official notice.

Source date Jun 23, 2023. Retrieved Oct 1, 2026. Last updated Oct 1, 2026.

Archive changed Oct 1, 2026. USDA FSIS records are unavailable; check FSIS directly. Source coverage and dates.

What the record says

Product
Safe Tussin DM Cough + Chest Congestion (Dextromethorphan HBr/ Cough Suppressant Guaifenesin/Expectorant), packaged in 4.0 FL OZ(118mL), 2020 Kramer Laboratories, Inc. Bridgewater, NJ 08807
Reason
CGMP Deviations: use of non-food grade lubricant in mixing vessel.
Classification
Class II
Recalling firm
Kramer Laboratories, Inc.
Quantity
N/A
Agency-reported status
Terminated
Source record identifier
D-0942-2023

Open the official record

What the recall classes mean. Classification is an agency assessment, not individual medical advice.

Lot and product identifiers

Label fieldDetails supplied by the agency
Lot, code or applicabilityLot #: 8753, 8753A, Exp. Date 10/2023 Lot #: 8659 Exp. Date 8/2023

Match all identifying details in the current notice. A brand name alone is not enough.

Distribution

nationwide within the United States

States below are derived from the distribution text, including nationwide wording. They are not inferred from the firm's address.

Dates in the source

Report date
Aug 2, 2023
Recall initiation date
Jun 23, 2023
Center classification date
Jul 24, 2023
Termination date
Mar 12, 2024

FDA company pages use the listing date; enforcement records use initiation dates; CPSC uses recall date; NHTSA uses report-received date. These dates are not interchangeable.

Related records